179 related articles for article (PubMed ID: 17613659)
1. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis.
Adibkia K; Siahi Shadbad MR; Nokhodchi A; Javadzedeh A; Barzegar-Jalali M; Barar J; Mohammadi G; Omidi Y
J Drug Target; 2007 Jul; 15(6):407-16. PubMed ID: 17613659
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits.
Adibkia K; Omidi Y; Siahi MR; Javadzadeh AR; Barzegar-Jalali M; Barar J; Maleki N; Mohammadi G; Nokhodchi A
J Ocul Pharmacol Ther; 2007 Oct; 23(5):421-32. PubMed ID: 17900230
[TBL] [Abstract][Full Text] [Related]
3. Naproxen-eudragit RS100 nanoparticles: preparation and physicochemical characterization.
Adibkia K; Javadzadeh Y; Dastmalchi S; Mohammadi G; Niri FK; Alaei-Beirami M
Colloids Surf B Biointerfaces; 2011 Mar; 83(1):155-9. PubMed ID: 21130612
[TBL] [Abstract][Full Text] [Related]
4. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen.
Pignatello R; Bucolo C; Ferrara P; Maltese A; Puleo A; Puglisi G
Eur J Pharm Sci; 2002 Jul; 16(1-2):53-61. PubMed ID: 12113891
[TBL] [Abstract][Full Text] [Related]
5. Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits.
Tayel SA; El-Nabarawi MA; Tadros MI; Abd-Elsalam WH
AAPS PharmSciTech; 2013 Jun; 14(2):782-93. PubMed ID: 23615773
[TBL] [Abstract][Full Text] [Related]
6. Triamcinolone acetonide-Eudragit(®) RS100 nanofibers and nanobeads: Morphological and physicochemical characterization.
Payab S; Davaran S; Tanhaei A; Fayyazi B; Jahangiri A; Farzaneh A; Adibkia K
Artif Cells Nanomed Biotechnol; 2016; 44(1):362-9. PubMed ID: 25180944
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
8. Preparation of solid dispersions of nonsteroidal anti-inflammatory drugs with acrylic polymers and studies on mechanisms of drug-polymer interactions.
Pignatello R; Ferro M; Puglisi G
AAPS PharmSciTech; 2002; 3(2):E10. PubMed ID: 12916947
[TBL] [Abstract][Full Text] [Related]
9. Preparation and physicochemical characterization of naproxen-PLGA nanoparticles.
Javadzadeh Y; Ahadi F; Davaran S; Mohammadi G; Sabzevari A; Adibkia K
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):498-502. PubMed ID: 20719477
[TBL] [Abstract][Full Text] [Related]
10. Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation.
El-Habashy SE; Allam AN; El-Kamel AH
Int J Nanomedicine; 2016; 11():2369-80. PubMed ID: 27307735
[TBL] [Abstract][Full Text] [Related]
11. Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery.
Katara R; Sachdeva S; Majumdar DK
Pharm Dev Technol; 2019 Mar; 24(3):368-379. PubMed ID: 29897843
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of piroxicam-HPMCAS solid dispersions for ocular use.
Jachowicz R; Czech A
Pharm Dev Technol; 2008; 13(6):495-504. PubMed ID: 18720246
[TBL] [Abstract][Full Text] [Related]
13. Enhanced ocular anti-inflammatory activity of ibuprofen carried by an Eudragit RS100 nanoparticle suspension.
Bucolo C; Maltese A; Puglisi G; Pignatello R
Ophthalmic Res; 2002; 34(5):319-23. PubMed ID: 12381895
[TBL] [Abstract][Full Text] [Related]
14. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and evaluation of Eudragit
Chantasart D; Tocanitchart P; Wongrakpanich A; Teeranachaideekul V; Junyaprasert VB
Pharm Dev Technol; 2018 Oct; 23(8):771-779. PubMed ID: 28406344
[TBL] [Abstract][Full Text] [Related]
16. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
Katara R; Majumdar DK
Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
[TBL] [Abstract][Full Text] [Related]
17. Piroxicam bioadhesive ocular inserts: physicochemical characterization and evaluation in prostaglandin-induced inflammation.
Gilhotra RM; Gilhotra N; Mishra DN
Curr Eye Res; 2009 Dec; 34(12):1065-73. PubMed ID: 19958126
[TBL] [Abstract][Full Text] [Related]
18. Moxifloxacin loaded nanoparticles of disulfide bridged thiolated chitosan-eudragit RS100 for controlled drug delivery.
Iqbal O; Shah S; Abbas G; Rasul A; Hanif M; Ashfaq M; Afzal Z
Int J Biol Macromol; 2021 Jul; 182():2087-2096. PubMed ID: 34087298
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characterization of nebivolol nanoparticles using Eudragit® RS100.
Jana U; Mohanty AK; Manna PK; Mohanta GP
Colloids Surf B Biointerfaces; 2014 Jan; 113():269-75. PubMed ID: 24140793
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of piroxicam from novel solid lipid microparticles formulated with homolipids from Bos indicus.
Nnamani PO; Attama AA; Kenechukwu FC; Ibezim EC; Adikwu MU
Curr Drug Deliv; 2013 Dec; 10(6):645-55. PubMed ID: 23140234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
